February 04, 2026 a 07:43 pm

MRK: Fundamental Ratio Analysis - Merck & Co., Inc.

Merck & Co., Inc. - Company Overview

Merck & Co., Inc. is a global leader in the healthcare industry, operating through pharmaceutical and animal health segments. The company has a strong presence in various therapeutic areas and a robust pipeline of innovative treatments. Its strategic collaborations further enhance its potential for growth.

Fundamental Rating

Merck & Co., Inc. shows strong financial health with impressive fundamental scores in key areas, indicating a stable investment opportunity.

Category Score Visualization
Discounted Cash Flow (DCF) 5
Return on Equity (ROE) 5
Return on Assets (ROA) 5
Debt to Equity 1
Price to Earnings (P/E) 3
Price to Book (P/B) 2

Historical Rating

The ratings history shows consistent performance, underscoring Merck's ability to maintain financial stability.

Date Overall DCF ROE ROA Debt/Equity P/E P/B
2026-02-04 4 5 5 5 1 3 2
Historical Date 0 5 5 5 1 3 2

Analyst Price Targets

Analysts are optimistic about Merck's future, with a consensus target above the current market price.

High Low Median Consensus
136 90 122 119.91
MRK Stock Chart

Analyst Sentiment

The sentiment analysis shows a strong inclination towards buying the stock, reflecting confidence in Merck's potential.

Recommendation Number Distribution
Buy 25
Hold 10
Sell 1

Conclusion

Merck & Co., Inc. presents potential as a robust investment due to its strong market position in healthcare and solid financial metrics. While there are risks associated with market competition and regulatory changes, the company’s innovative pipeline and strategic collaborations enhance its growth prospects. Meanwhile, analysts maintain an optimistic outlook, reflecting confidence in sustained profitability. Investors should consider market conditions and ongoing developments in the healthcare industry before making a decision.